Top 5 Biologicals from European Biopharma to Launch in 2017
A new report listing the top drug launches this year reveals the strong performance of…
31/01/2017 - 2 minutes
AstraZeneca
The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge
Cambridge's image is tied to its Hogwarts-like University and Nobel-hoarding academia, but there's also an…
30/01/2017 - 8 minutes
An EU Project will tackle Multiple Sclerosis using Personalized Multi Omics
The MultipleMS Consortium has been granted €15M by the EU Horizon 2020 to improve the…
02/01/2017 - 2 minutes
Stories We Didn’t Cover: Next Human CRISPR Trials by Intellia?
Try as we might, we can't cover all the biotech news out there. During the…
09/12/2016 - 2 minutes
Stories We Didn’t Cover: MDMA in Phase III, Another Death for Carmat
Try as we might, we can't cover all the biotech news out there. During the…
02/12/2016 - 2 minutes
Better than ADCs? AstraZeneca bids for Bicyclic Peptides
AstraZeneca has signed a deal with Bicycle Therapeutics that could exceed €1B. The foundation is…
02/12/2016 - 2 minutes
And the highest funding in Europe this year goes to… Antibody-Drug Conjugates!
AstraZeneca has contributed to ADC Therapeutics' €96M fundraising, the biggest round so far in Europe…
19/10/2016 - 3 minutes
Boehringer buys a €210M ticket to Virus-based Immuno-Oncology
Boehringer Ingelheim has signed a deal with ViraTherapeutics, an Austrian start-up that focuses on the…
29/09/2016 - 2 minutes
A new player has entered the Game: €29M for DDR Cancer Therapy
Artios Pharma, launched in May this year, just received €29M (£25M) in Series A to develop…
21/09/2016 - 3 minutes
mRNA Money-magnet increases its Pile of Cash to over €1.3Bn
Moderna is taking Biotech investing to new heights, as it has now increased total fundraising&partnership…
12/08/2016 - 2 minutes
AstraZeneca plans Phase I trial with mRNA therapy for Cardiovascular Disease
The collaboration between AstraZeneca and the money-magnet Moderna is giving its first steps. AstraZeneca is…
27/07/2016 - 3 minutes
Danish Pharma enters in the Biologics arena with Antibody Buy-out
Leo Pharma is acquiring rights to two of AstraZeneca's candidates. The targeted indications are atopic…
04/07/2016 - 3 minutes
